HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-κB p65 signaling pathway.

Abstract
The morbidity and mortality associated with influenza A virus infections, have stimulated the search for novel prophylactic and therapeutic drugs. The purpose of this study was to investigate the prophylactic and therapeutic effect of synthetic methionine enkephalin (MENK) on mice infected by A/PR/8/34 influenza virus (H1N1) in vivo. The results showed that MENK could exert both prophylactic and therapeutic influences on infected mice, significantly improve the survival rate, relieve acute lung injury and decrease cytokine (IFN-α, IFN-β, TNF-α, IL-6, and IL-1β) levels. MENK also inhibited virus replication on day 4 post infection (p.i.) through upregulating opioid receptors (MOR, DOR) and suppressing TLR7-MyD88-TRAF6-NF-κB p65 signaling pathways. These results suggest that MENK, given via intranasal administration, could provide a novel drug with a new mode of action as a nonspecific anti-influenza agent or vaccine adjuvant.
AuthorsJing Tian, Xue Jiao, Xiaonan Wang, Jin Geng, Reizhe Wang, Ning Liu, Xinhua Gao, Noreen Griffin, Fengping Shan
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 55 Pg. 38-48 (Feb 2018) ISSN: 1878-1705 [Electronic] Netherlands
PMID29220721 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier B.V. All rights reserved.
Chemical References
  • Antiviral Agents
  • Cytokines
  • Inflammation Mediators
  • Membrane Glycoproteins
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Receptors, Opioid
  • TNF Receptor-Associated Factor 6
  • Tlr7 protein, mouse
  • Toll-Like Receptor 7
  • Enkephalin, Methionine
Topics
  • Animals
  • Antiviral Agents (therapeutic use)
  • Cytokines (metabolism)
  • Enkephalin, Methionine (therapeutic use)
  • Female
  • Humans
  • Inflammation Mediators (metabolism)
  • Influenza A Virus, H1N1 Subtype (physiology)
  • Influenza, Human (drug therapy)
  • Lung (metabolism, pathology)
  • Membrane Glycoproteins (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Myeloid Differentiation Factor 88 (metabolism)
  • NF-kappa B (metabolism)
  • Orthomyxoviridae Infections (drug therapy)
  • Receptors, Opioid (metabolism)
  • Signal Transduction
  • TNF Receptor-Associated Factor 6 (metabolism)
  • Toll-Like Receptor 7 (metabolism)
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: